The approval for the drug, which comes after an initial rejection from the FDA in January last year, lifted Pfizer's shares marginally and Opko Health over 27% in premarket trading.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/36IohPW
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» US FDA approves Pfizer-OPKO's drug for growth hormone deficiency in kids
https://ift.tt/YAuGo3Q
No comments:
Post a Comment